SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52
出版年份 2022 全文链接
标题
SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52
作者
关键词
-
出版物
Cell Death & Disease
Volume 13, Issue 2, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-02-24
DOI
10.1038/s41419-022-04630-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2
- (2021) Shourong Wang et al. Cell Death & Disease
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients
- (2020) Vincent Ho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SF3b4: A Versatile Player in Eukaryotic Cells
- (2020) Feng Xiong et al. Frontiers in Cell and Developmental Biology
- SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma
- (2020) SHINYA KIDOGAMI et al. ANTICANCER RESEARCH
- Roles and mechanisms of alternative splicing in cancer — implications for care
- (2020) Sophie C. Bonnal et al. Nature Reviews Clinical Oncology
- Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity
- (2020) Ilenia Pellarin et al. ONCOGENE
- Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation
- (2020) Pooja Popli et al. Cell Death & Disease
- Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy
- (2019) Tomoki Yamano et al. Oncotarget
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- SF3B2-mediated RNA splicing drives human prostate cancer progression
- (2019) Norihiko Kawamura et al. CANCER RESEARCH
- Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
- (2019) Ping Li et al. Cancer Cell International
- RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
- (2019) Toma et al. Cancers
- Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
- (2018) Katherine Sullivan-Reed et al. Cell Reports
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma
- (2018) Zhiyong Liu et al. EBioMedicine
- miR-509-3p enhances platinum drug sensitivity in ovarian cancer
- (2018) Leilei Niu et al. GENE
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells
- (2017) Wentao Zhou et al. TUMOR BIOLOGY
- Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
- (2016) Ke Chen et al. CLINICAL CANCER RESEARCH
- Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations
- (2016) Constantin Cretu et al. MOLECULAR CELL
- miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
- (2016) Yinghong Pan et al. Oncotarget
- Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer
- (2015) K-F Hsu et al. BRITISH JOURNAL OF CANCER
- Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus
- (2015) Rachel Lieberman et al. MOLECULAR CARCINOGENESIS
- Splicing proofreading at 5′ splice sites by ATPase Prp28p
- (2013) Fei Yang et al. NUCLEIC ACIDS RESEARCH
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
- (2010) Ryohei Furumai et al. CANCER SCIENCE
- Expansion of the eukaryotic proteome by alternative splicing
- (2010) Timothy W. Nilsen et al. NATURE
- Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells
- (2009) B. J. Albert et al. MOLECULAR CANCER THERAPEUTICS
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now